Microbiome research promises to transform human health; however, until now the field has been held back by the challenges of translating microbiome data into novel treatments, ingredients, diagnostics, and other healthcare solutions. A number of […]
MRM Health NV, a clinical-stage biopharmaceutical company focused on developing next-generation live microbiome consortia therapeutics, today reports positive topline results from its Phase 2a clinical trial with MH002 in mild-to-moderate Ulcerative Colitis (UC). MRM Health’s […]
Probiotics engineered to sense and report signs of bowel inflammation could deliver first hand knowledge of your system’s inner workings ⎯ provided they are not killed or dispersed in the process. Working toward making this […]
Introduction In medicine, women’s health refers to the category of conditions and experiences that are unique to women such as pregnancy and menstruation. The term can also be applied to conditions experienced by both men […]
Orally delivered APIs must survive the harsh acidic conditions of the upper gastrointestinal tract to reach their target destination and remain viable. To overcome this challenge Lonza Capsules & Health Ingredients have developed groundbreaking enteric […]
A new international study conducted by the Israeli Phage Therapy Center (IPTC) led by Prof. Ran Nir-Paz at Hadassah Hebrew University Medical Center and Prof. Ronen Hazan of the Faculty of Dental Medicine at The […]
The composition and metabolic output of the human gut microbiome is shaped by several environmental factors, an important one being diet. To better understand the relationship between diet and microbiome function researchers must develop methods […]
Asthma is a major cause of disability, poor quality of life world-wide and health resource utilization. The World Health Organisation (WHO) estimated that 262 million people suffered from asthma in 2019 and it caused 455 […]
Bloom Science, Inc., a clinical-stage, central nervous system (CNS) company focused on discovering and developing breakthrough therapeutics that target the Gut-Brain Axis for neurological diseases, today announced positive results from its Phase 1 clinical study […]
Aspergillus fumigatus strains that infect humans have a significantly altered metabolism compared to other strains in the environment. At the same time, infection with the fungus leads to an apparent change in the human lung microbiome. […]
Multiple sclerosis (MS) is an inflammatory autoimmune disease of the central nervous system. It is triggered by certain T cells, which infiltrate the brain and spinal cord and attack the insulating myelin sheath around axons. […]